168Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Brazil
Neuroscience Intelligence
Brazil neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #16 of 50 · Data maturity A · Research score 40.9 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
38Recruiting trials
208Publications
119Institutions
Executive interpretation
Brazil ranks #16 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC189 recruiting
Hoffmann-La Roche125 recruiting
University of Sao Paulo110 recruiting
Hospital de Clinicas de Porto Alegre100 recruiting
University of Sao Paulo General Hospital101 recruiting
Federal University of Paraíba71 recruiting
Federal University of Rio Grande do Sul70 recruiting
Universidade Federal de Pernambuco71 recruiting
Federal University of Minas Gerais41 recruiting
GlaxoSmithKline40 recruiting
Disease activity
Parkinsons47trials
Alzheimers22trials
Pain Neuropathy14trials
Adhd12trials
Epilepsy12trials
Depression8trials
Multiple Sclerosis8trials
Stroke7trials
Autism6trials
Schizophrenia6trials
Research institutions
Hospital do CoraçãoOpenAlexlinked institution
Universidade Federal do Estado do Rio de JaneiroOpenAlexlinked institution
Universidade de Santo AmaroOpenAlexlinked institution
Universidade Federal de GoiásOpenAlexlinked institution
Universidade de FortalezaOpenAlexlinked institution
Pontifícia Universidade Católica do Rio de JaneiroOpenAlexlinked institution
Instituto do Câncer do Estado de São PauloOpenAlexlinked institution
Hospital Alemão Oswaldo CruzOpenAlexlinked institution
Universidade Federal de Santa CatarinaOpenAlexlinked institution
Beneficência Portuguesa de São PauloOpenAlexlinked institution
Clinical evidence trail
NCT07523126EFFECT OF TRANSCUTANEOUS ELECTRONEURO-STIMULATION OF THE VAGUS NERVE ON JOINT PAIN SEQUELAE OF CHIKUNGUNYA FEVER IN THE LOWER LIMBSACTIVE_NOT_RECRUITING
NCT07221669A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)RECRUITING
NCT07216703A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)RECRUITING
NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRECRUITING
NCT07170150A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRECRUITING
NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)RECRUITING
NCT07010471A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineACTIVE_NOT_RECRUITING
NCT06976216A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseaseRECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
Research evidence trail
PUBMEDInvestigation of the predictive value of routine electroencephalogram compared to continuous electroencephalogram in the acute phase of traumatic brain injury.2027-01-01
PUBMEDTactile stimulation modulates withdrawal-related behaviors and brain molecular parameters in male offspring following perinatal morphine exposure.2026-12-15
PUBMEDCardiorespiratory fitness in people with bipolar disorder: A systematic review and meta-analysis.2026-12-15
PUBMEDEducation Research: Career, Research, and Mentorship Outcomes of an International Neuroimmunology Education Exchange Program.2026-12-01
PUBMEDClozapine for Severe Treatment-Resistant Disruptive Behaviors in Youth with Autism Spectrum Disorder: A Prospective Real-World Interventional Study.2026-12-01
PUBMEDAppearance and Attitude in the Mental Status Examination: Psychopathological Perspectives.2026-12-01
PUBMEDRedox modulation contributes to the antidepressant-like and neuroprotective effects of 7-chloro-4-(phenylselanyl)quinoline in an Alzheimer's disease model.2026-12-01
PUBMEDInfralimbic cortex neurostimulation attenuates nociceptive and affective manifestations in a reserpine-induced fibromyalgia model.2026-12-01
PUBMEDCircadian misalignment in healthy young adults influences the variability of inhibitory performance modeled by the horse race model.2026-12-01
PUBMEDA topological architecture of neurodivergence: Transdiagnostic reframing of autism, ADHD, dyslexia, DCD, and high-ability profiles within the high processing cost phenotypes (HPCPh) framework.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.